Arnoud J Templeton

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 11

Top Topics

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Nature reviews. Clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ken Kudura, Nando Ritz, Arnoud J Templeton, Tim Kutzker, Martin H K Hoffmann, Kwadwo Antwi, Daniel Rudolf Zwahlen, Michael Christoph Kreissl, Robert Foerster
An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data. Cancers 15 (22) (2023)
Ken Kudura, Nando Ritz, Arnoud J Templeton, Marc Kissling, Tim Kutzker, Robert Foerster, Martin H K Hoffmann, Kwadwo Antwi, Michael Christoph Kreissl
Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival. Cancers 15 (5) (2023)
Ivana Bratic Hench, Luca Roma, Floriana Conticelli, Lenard Bubendorf, Byron Calgua, Clémentine Le Magnen, Salvatore Piscuoglio, Mark A Rubin, Alin Chirindel, Guillaume P Nicolas, Tatjana Vlajnic, Tobias Zellweger, Arnoud J Templeton, Frank Stenner, Christian Ruiz, Cyrill A Rentsch, Lukas Bubendorf
Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer. Cancers 16 (1) (2023)
Ivana Bratic Hench, Luca Roma, Floriana Conticelli, Lenard Bubendorf, Byron Calgua, Clémentine Le Magnen, Salvatore Piscuoglio, Mark A Rubin, Alin Chirindel, Guillaume P Nicolas, Tatjana Vlajnic, Tobias Zellweger, Arnoud J Templeton, Frank Stenner, Christian Ruiz, Cyrill A Rentsch, Lukas Bubendorf
Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer. Cancers 16 (1) (2023)
Ken Kudura, Nando Ritz, Arnoud J Templeton, Marc Kissling, Tim Kutzker, Robert Foerster, Martin H K Hoffmann, Kwadwo Antwi, Michael Christoph Kreissl
Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival. Cancers 15 (5) (2023)
Ken Kudura, Nando Ritz, Tim Kutzker, Martin H K Hoffmann, Arnoud J Templeton, Robert Foerster, Michael Christoph Kreissl, Kwadwo Antwi
Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors. Cancers 14 (24) (2022)
Ken Kudura, Nando Ritz, Tim Kutzker, Martin H K Hoffmann, Arnoud J Templeton, Robert Foerster, Michael Christoph Kreissl, Kwadwo Antwi
Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors. Cancers 14 (24) (2022)
Roman Adam, Ariadna Tibau, Consolación Molto Valiente, Boštjan Šeruga, Alberto Ocaña, Eitan Amir, Arnoud J Templeton
Clinical benefit of cancer drugs approved in Switzerland 2010-2019. PloS one 17 (6) (2022)
Ken Kudura, Nando Ritz, Tim Kutzker, Martin H K Hoffmann, Arnoud J Templeton, Robert Foerster, Michael Christoph Kreissl, Kwadwo Antwi
Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors. Cancers 14 (24) (2022)
Arnoud J Templeton, Eitan Amir, Ian F Tannock
Informative censoring - a neglected cause of bias in oncology trials. Nature reviews. Clinical oncology 17 (6) (2020)
Arnoud J Templeton, Laura Diez Gonzalez, Francisco E Vera-Badillo, Ariadna Tibau, Robyn Goldstein, Boštjan Šeruga, Amirrtha Srikanthan, Atanasio Pandiella, Eitan Amir, Alberto Ocana
Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression. PloS one 11 (5) (2016)